Breast cancer and antidepressant use

14Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

■Tamoxifen, an antiestrogen drug, is used for many indications related to breast cancer. Antidepressants are also often used in breast cancer patients, for states such as depression, anxiety, and hot flashes associated with chemical menopause. ■Tamoxifen is a prodrug. Some antidepressants (eg, paroxetine, fluoxetine, bupropion, duloxetine) inhibit CYP2D6, the enzyme that converts tamoxifen into endoxifen, its most important active metabolite. This could compromise tamoxifen's efficacy. ■Clinicians should avoid CYP2D6 inhibitors in patients receiving tamoxifen in favor of drugs with low or no CYP2D6 inhibitor activity (eg, mirtazapine, escitalopram, fluvoxamine, reboxetine, citalopram, sertraline, venlafaxine, desvenlafaxine). © Copyright 2012 Physicians Postgraduate Press, Inc.

Cite

CITATION STYLE

APA

Andrade, C. (2012). Breast cancer and antidepressant use. Journal of Clinical Psychiatry, 73(9). https://doi.org/10.4088/JCP.12f08054

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free